Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARVINAS, INC. | Chief Financial Officer | Common Stock | 182K | $8.56M | $47.05 | Feb 23, 2024 | Direct |
HOOKIPA Pharma Inc. | Director | Stock Option (Right to Buy) | 9.8K | Jul 22, 2024 | Direct | ||
ARVINAS, INC. | Chief Financial Officer | Restricted Stock Units | 0 | Mar 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HOOK | HOOKIPA Pharma Inc. | Jul 22, 2024 | 1 | $0 | 4 | Jul 24, 2024 | Director |
HOOK | HOOKIPA Pharma Inc. | Jul 22, 2024 | 0 | $0 | 3 | Jul 24, 2024 | Director |
ARVN | ARVINAS, INC. | Feb 23, 2024 | 1 | -$80.1K | 4 | Feb 27, 2024 | Chief Financial Officer |
ARVN | ARVINAS, INC. | Mar 1, 2023 | 3 | -$51.5K | 4 | Mar 3, 2023 | Chief Financial Officer |
ARVN | ARVINAS, INC. | Feb 22, 2023 | 2 | $0 | 4 | Feb 24, 2023 | Chief Financial Officer |
ARVN | ARVINAS, INC. | Mar 11, 2022 | 3 | -$1.05M | 4 | Mar 15, 2022 | Chief Financial Officer |
ARVN | ARVINAS, INC. | Feb 23, 2022 | 4 | -$102K | 4 | Mar 4, 2022 | Chief Financial Officer |
ARVN | ARVINAS, INC. | Dec 17, 2021 | 3 | -$810K | 4 | Dec 21, 2021 | Chief Financial Officer |
ARVN | ARVINAS, INC. | Jul 28, 2021 | 3 | -$1.45M | 4 | Jul 30, 2021 | Chief Financial Officer |